Abstract
Cigarette smoking is associated with low plasma high-density lipoprotein cholesterol (HDL-C) and apolipoprotein (apo) A-I levels, which may explain, in part, its deleterious effects on coronary heart disease (CHD). In a group of ex-smokers, we assessed the influence of smoking cessation on apo A-I particle levels. Plasma lipid, apolipoprotein, and lipoparticle concentrations of 58 subjects who had completely stopped smoking (ex-smokers) were compared with those of 37 subjects who had continued smoking (smokers) before and after a smoking cessation counseling program. Nutritional intake was recorded before and after the program to adjust for potential interaction with plasma lipid variables. Smokers and ex-smokers were similar in gender distribution, age, body mass index (BMI), social status, and nutrient intake. There were significantly greater increases in total cholesterol (P < .04), HDL-C (P < .005), HDL2-C (P < .008), and lipoprotein (Lp) A-I:A-II (P < .04) in ex-smokers than in smokers. After smoking cessation, ex-smokers consumed more vegetable protein (P < .02) and polysaccharides (P < .04) and had higher plasma levels of HDL-C (P < .0004), apo A-I (P < .001), Lp A-I (P < .007), and Lp A-I:A-II (P < .01) than smokers. Ad...Continue Reading
References
Nov 1, 1979·Atherosclerosis·K BergG Dahlen
May 9, 1992·Lancet·F S FacchiniG M Reaven
Apr 1, 1991·Pathology·J R MasareiW J Lynch
Jan 15, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·E H MoriguchiY Goto
Aug 8, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
Jan 25, 1990·The New England Journal of Medicine·L RosenbergS Shapiro
Mar 25, 1989·BMJ : British Medical Journal·W Y CraigJ E Haddow
Feb 1, 1989·Atherosclerosis·M QuenselP Nilsson-Ehle
Oct 1, 1989·The American Journal of Clinical Nutrition·P MilletJ Klepping
Nov 1, 1988·Atherosclerosis·R J Moffatt
Jan 1, 1986·Preventive Medicine·J TuomilehtoK Koskela
Mar 8, 1984·The New England Journal of Medicine·R M Carney, A P Goldberg
May 22, 1982·British Medical Journal·I StubbeP Nilsson-Ehle
May 1, 1995·Preventive Medicine·D J HennrikusH A Lando
Aug 19, 1995·BMJ : British Medical Journal·S ParishS Cederholm-Williams
Dec 1, 1994·Current Opinion in Lipidology·A von EckardsteinG Assmann
May 1, 1995·Journal of Internal Medicine·M AxelsenU Smith
Feb 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·T O'BrienB A Kottke
Feb 1, 1995·American Journal of Public Health
Aug 1, 1993·International Journal of Epidemiology·K HughesP P Yeo
Oct 1, 1993·European Journal of Clinical Investigation·D J FreemanJ Shepherd
Oct 1, 1995·Current Opinion in Lipidology·A LeroyJ C Fruchart
Mar 1, 1996·Atherosclerosis·P J Barter, K A Rye
Citations
Aug 10, 2011·Drug Metabolism Reviews·Marwa E Elsherbiny, Dion R Brocks
Dec 1, 2015·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Frank LüdickeRolf Weitkunat
Feb 5, 1999·Electrophoresis·M LindahlC Tagesson
Jan 13, 2000·Journal of Addictive Diseases·W W Sloan
Jun 22, 2014·Current Cardiology Reports·Carlos G Santos-Gallego, Robert S Rosenson
Aug 24, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Maryam ZaidUNKNOWN INTERLIPID and INTERMAP Research Groups
Jul 16, 2013·Journal of Cellular Biochemistry·Bai-mei HeZhen-yu Peng
Sep 19, 1998·Medicine and Science in Sports and Exercise·R NiauraD Abrams
Mar 17, 1999·Journal of the Royal Society of Health·D P MikhailidisE S Ganotakis
Dec 15, 2000·European Journal of Clinical Investigation·F W van den BerkmortelA F Stalenhoef
Aug 12, 2004·Pharmacotherapy·Lyne LalondeSteven A Grover
Nov 21, 2013·Biomarker Research·Barbara A ForeyKatharine J Coombs
Sep 22, 2000·Atherosclerosis·G LucP Ducimetiere
Jun 17, 1998·Metabolism: Clinical and Experimental·S R SrinivasanG S Berenson
Jul 23, 1998·The Surgical Clinics of North America·M L TerryM D Kerstein
Mar 27, 2010·Journal of the American College of Cardiology·Pradeep NatarajanChristopher P Cannon